Who carries the relevant structural phenotype before treatment?
Prospective studies can test whether baseline trap burden, cargo or cell relationships associate with a defined response endpoint.
APPLICATIONSOne circulating structure.
One circulating structure.
Different disease questions.
Extracellular DNA traps are implicated across immune escape, autoimmunity, thrombosis and dysregulated host defense. Preserving their architecture creates a shared spatial measurement layer for translational research.
01 / DISEASE AREAS
One circulating structure.
Different disease questions.
Extracellular DNA traps have been implicated across immune escape, autoimmunity, thrombosis and dysregulated host defense. Preserving their architecture adds a spatial measurement layer to each field.
An extracellular web wraps the tumor cluster while checkpoint-associated cargo and cytotoxic pressure remain visible at its edge.
Emerging research directions Pulmonary inflammation · reproductive inflammation · inflammatory tissue injury
Investigational research applications · NET-specific attribution requires marker panels and study controls02 / TRANSLATIONAL QUESTIONS
Three ways the platform
can support drug development.
Each application begins as a defined research question and requires prospective validation in the intended cohort and decision context.
Does the circulating trap landscape remodel after intervention?
Matched collections can compare burden, size distribution and structural persistence across clinically relevant timepoints.
Do persistent structures reveal biology that soluble markers miss?
Structure-resolved imaging can test whether intact objects and fragmented signal change together or diverge over time.
03 / EXPLORATORY OBSERVATIONS
Measure structural response
across treatment.
Early matched observations illustrate two distinct patterns: overall burden reduction and residual structural persistence.
TWO LONGITUDINAL RESPONSE PATTERNS
Compare burden reduction with structural persistence side by side.
01BURDEN REDUCTION
STAGE I CRC · MATCHED PRE/POST-RESECTIONA structural burden that falls after intervention.
Total circulating trap burden decreased into the healthy-reference range two weeks after resection.
TOTAL TRAP BURDENHigh
POST-INTERVENTIONWithin healthy reference
02STRUCTURAL PERSISTENCE
SLE · MATCHED PRE/POST-IMMUNOSUPPRESSIONSignal falls, but large structures persist.
Fragmented extracellular-DNA signal decreased after immunosuppression, while large circulating trap-like structures remained detectable.
FRAGMENTED SIGNALReduced
LARGE STRUCTURESRemain detectable
Exploratory matched observations · Research use only · Prospective validation required